Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent advances: Personalised use of current Crohn's disease therapeutic options.

Gut - 1 Oct 2013

Vermeire Séverine, Ferrante Marc, Rutgeerts Paul

Abstract excerpt

Several aspects of the management of Crohn's disease (CD) are shared between patients. The goal of all therapies should be to achieve clinical and endoscopic remission in a timely manner to avoid disease progression and abdominal resections. The way this goal is achieved may differ and predicting how the disease will evolve, what the most appropriate therapy with the highest chance of success will be, how long a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Crohn Disease
Share to Drug Monitoring

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunologic Factors

Share to Precision Medicine

Share to Prognosis

Share to Remission Induction

Share to Tumor Necrosis Factor-alpha

Source

Identifiers

PMID: 24037876
DOI: 10.1136/gutjnl-2012-303958

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent advances: Personalised use of current Crohn's disease therapeutic options.PMID 24037876Read ↗

Evolving Treatment Algorithms in Crohn's Disease.Semantic proximity Read ↗

Personalizing therapy for inflammatory bowel diseases.Semantic proximity Read ↗

Personalizing therapy selection in inflammatory bowel disease.Semantic proximity Read ↗

Pharmacogenetics of inflammatory bowel disease: a focus on Crohn's disease.Semantic proximity Read ↗

Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice.Semantic proximity Read ↗

Preoperative Optimisation for Elective Surgery in Crohn’s DiseaseSemantic proximity Read ↗

Review article: a critical approach to new forms of treatment of Crohn's disease and ulcerative colitis.Semantic proximity Read ↗

[Progress in diagnosis and treatment of Crohn disease].Semantic proximity Read ↗

The changing face of Crohn's disease: a population-based study of the natural history of Crohn's disease in Örebro, Sweden 1963-2005.Semantic proximity Read ↗

Does the phenotype of Crohn's disease in an individual remain stable over time?Semantic proximity Read ↗

78 Longitudinal Status of Serological Markers Predict Crohn's Disease Phenotype Before Diagnosis: A ‘PREDICTS’ StudySemantic proximity Read ↗

Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.